Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (100.0%)Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee
Phase 3
Withdrawn
- Conditions
- Acute Pain (Flare) Associated With Osteoarthritis (OA) of the Knee
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-07-02
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Imprimis Pharmaceuticals, Inc.
- Registration Number
- NCT01890902
Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2012-09-05
- Lead Sponsor
- Imprimis Pharmaceuticals, Inc.
- Registration Number
- NCT01223053
Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury
Phase 3
Completed
- Conditions
- SprainStrainAcute Soft Tissue Injury
- Interventions
- Drug: Topical Placebo Cream
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2013-09-27
- Lead Sponsor
- Imprimis Pharmaceuticals, Inc.
- Target Recruit Count
- 364
- Registration Number
- NCT00765700
- Locations
- 🇺🇸
CATO Research, Durham, North Carolina, United States
News
No news found